Search
All Posts
How to Turn No Experience Into a Winning Regulatory Affairs CV: Your Complete Guide to Breaking Into the Regulatory Affairs
Breaking into regulatory affairs without prior experience might seem like an impossible challenge, but thousands of professionals have successfully made this transition from diverse backgrounds including academia, healthcare, engineering, and even completely unrelated fields. The regulatory affairs industry is experiencing unprecedented growth, with companies desperately seeking talented individuals who can navigate the complex world of pharmaceutical and medical device compl
Sep 29, 20256 min read
Introduction to Regulatory Affairs Course
Are you looking for an entry level role in regulatory affairs? Gain work experience in regulatory affairs even if you are new to this field. This is the most comprehensive introductory regulatory affairs course available, providing you with a strong foundation in regulatory affairs by increasing your baseline knowledge, as well as offering you the hard to get real work experience to enhance your skills and job search support to secure a career in regulatory affairs. The compr
Feb 3, 20249 min read
Scientists Found a Hidden Immune Organ Inside the Human Skull — What It Means for Brain Cancer Treatment and Regulatory Affairs
Scientists at Washington University School of Medicine in St. Louis have identified a **skull immune organ** — lymphoid structures inside the skull's bone marrow that act as first responders to brain disease. Published in *Nature* on 19 August 2026, the study shows microscopic channels carry antigens from the brain into skull marrow, where **T follicular helper cells** train **B cells** to fight threats, including glioblastoma, before distant lymph nodes react. Similar cells
Aug 2812 min read
FDA's Streamlined Nonclinical Safety Guidance for Monoclonal Antibodies: What It Means for Regulatory Affairs Professionals in 2026
In December 2025, the US Food and Drug Administration (FDA) published draft guidance — "Monoclonal Antibodies: Streamlined Nonclinical Safety Studies" (Docket FDA-2025-D-4634) — recommending that sponsors of monospecific monoclonal antibodies (mAbs) can reduce or eliminate long-duration animal toxicology studies, including in nonhuman primates (NHPs), where a robust weight-of-evidence (WoE) risk assessment supports doing so. It affects any company developing single-target mAb
Aug 2511 min read
Overqualified but Under-Skilled: How PhDs and Postdocs Can Pivot Into Regulatory Affairs Careers
A PhD to regulatory affairs career change is one of the most viable moves available to scientists who find the academic job market unable to absorb them. Vitae's 2026 tracking data shows that although 91% of UK doctoral graduates are employed, 41% remain in higher education roles, 93% of which are on fixed-term contracts. Regulatory affairs offers permanent, well-paid, office-based roles that value scientific rigour — but PhDs typically lack the submission-specific skills (CT
Aug 1912 min read
We Analysed 196 Regulatory Affairs Career Changers — Here's What Actually Predicts Success
A regulatory affairs career change success analysis of 196 course registrants found that only 16 people (8.2%) transitioned into a regulatory affairs role, and their profiles differ sharply from the wider group. This affects anyone considering a move into regulatory affairs — scientists, pharmacists, graduates and existing regulatory professionals. The data, collected between September 2024 and May 2026, shows that active job searching, existing regulatory or science experien
Aug 1810 min read